Crescent Biopharma, Inc.CBIONASDAQ
Loading
Interest Income Over TimeExpanding
Percentile Rank86
3Y CAGR+59.1%
5Y CAGR+42.9%
Studio
Year-over-Year Change

Income earned from interest-bearing assets

3Y CAGR
+59.1%/yr
vs -31.4%/yr prior
5Y CAGR
+42.9%/yr
Recent acceleration
Acceleration
+90.5pp
Accelerating
Percentile
P86
Within normal range
vs 5Y Ago
6x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$2.88M+207.4%
2024$935275.00-60.6%
2023$2.38M+232.5%
2022$714520.00+3514.5%
2021$19768.00-95.9%
2020$482487.00-86.2%
2019$3.50M+8.2%
2018$3.23M+396.2%
2017$651212.00+528.3%
2016$103647.00-